middle.news
Bio-Gene Expands Asian Mosquito Trials and Secures US Patent to 2040
11:25am on Friday 31st of July, 2026 AEST
•
Agriculture
Read Story
Bio-Gene Expands Asian Mosquito Trials and Secures US Patent to 2040
11:25am on Friday 31st of July, 2026 AEST
Key Points
Expanded Flavocide and Qcide testing to Asian mosquito species
Ongoing OECD toxicity studies with September 2026 results expected
US patent allowance for Flavocide synergy extends IP to 2040
Progress on Qcide launch in Japan with Sumitomo and Nakashima
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bio-Gene Technology (ASX:BGT)
OPEN ARTICLE